RAPID DISPATCH
24/H dispatch
8 in stock
100% Secure transaction
LENISNA 200 is a hybrid biostimulator based on PDLLA polylactic acid and non-crosslinked hyaluronic acid, designed for tissue rejuvenation and restoration of skin volume. The formula combines an immediate effect, thanks to the hyaluronic acid that fills the treated areas, with a progressive stimulation of natural collagen production through PDLLA, improving skin tone, firmness and structure.
USE MEDICAL STRICT. Medical device. Use reserved for dermatologists and aesthetic doctors because they require a medical procedure.
.
Description
LENISNA 200 is a biostimulator with:
- The world's only hybrid formula based on Poly-D,L-Lactide and hyaluronic acid, with a particle size between 50 and 60 micrometres.
- Completely natural effect.
- Progressive release over time.
Details
- VAIM CO., LTD
- NAME: LENISNA 200
- COMPOSITION: PDLLA polylactic acid: 170 mg. Non-cross-linked hyaluronic acid: 30 mg.
- PRESENTATION: 1 x 200mg.
- INDICATIONS: LENISNA 200 is indicated for treating skin with visible signs of ageing, sunken areas of the face, furrows, wrinkles and folds, firming of relaxed skin on the face, arms, abdomen, thighs and buttocks.
- INJECTION DEPTH: Intradermal or subcutaneous. LENISNA 200 should be administered using a 22-25G gauge cannula or 25-26G gauge needles.
- DURATION: The effects of the therapy are visible immediately after administration, thanks to the filling action of the hyaluronic acid. After about two weeks, the production of collagen stimulated by PDLLA polylactic acid microparticles begins. Treatment results last more than two years after the last session. The recommended number of treatments is 2 or 3, depending on the skin imperfection, with intervals of 6-8 weeks. A maintenance session is recommended after two years.
- USE: Strict medical use.
Packaging
- Vial: 1 x 200mg.
Treatment zones
Face, inner thighs, abdomen, buttocks, arms.
Composition
PDLLA polylactic acid: 170 mg. Non-cross-linked hyaluronic acid: 30 mg.
Precautions for use
- LENISNA 200 should only be administered by qualified personnel.
- The application must take place under aseptic conditions, observing proper hygiene and preparation.
- Before use, the product should be diluted according to the manufacturer's instructions (e.g. sterile water or saline + 1-2 ml lidocaine) to improve the comfort of the procedure.
- A suitable cannula or needle (e.g. 22-25 G cannula or 25-26 G needle) should be used for injection into the subcutaneous tissue.
- The product is intended for use in selected suitable areas requiring toning or volumising (e.g. face, body).
- After preparation of the product, if not used immediately, the prescribed conditions (e.g. refrigerated storage times etc.) must be followed as per official protocols.
Contraindications
LENISNA 200 is contraindicated in the following cases:
- Pregnancy.
- Breastfeeding.
- Active infections.
- Collagen diseases.
- Active and uncontrolled autoimmune diseases.
- Allergy to product ingredients.
- Inflammation of the skin in the area intended for treatment.
Directions
LENISNA 200 is ideal for filling skin cavities, restoring and increasing soft tissue volume. It is recommended for reconstructive purposes in the treatment of morphological asymmetries
FAQ
.What is LENISNA 200?
It is an injectable biostimulator with a hybrid formula based on PDLLA and hyaluronic acid to volumise and stimulate collagen.
What imperfections does it treat?
Deep wrinkles, skin laxity, loss of volume and tissue defects on the face and body.
When do you see the results?
Immediately after the treatment for the filling effect; after about 2 weeks the stimulation of collagen begins.
How long do the effects last?
More than 2 years since the last session, with 2-3 treatments recommended.
How many sessions are needed?
Generally 2-3 treatments, spaced 6-8 weeks apart, with a maintenance session after about two years.
Italian 
English 